Scancell (LON:SCLP) Shares Cross Below Two Hundred Day Moving Average – Time to Sell?

Shares of Scancell Holdings plc (LON:SCLP) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 11.40 ($0.15) and traded as low as GBX 7.85 ($0.10). Scancell shares last traded at GBX 7.97 ($0.10), with a volume of 252,161 shares trading hands.

Scancell Stock Performance

The company has a market cap of £87.31 million, a price-to-earnings ratio of -12.92 and a beta of 0.35. The firm’s 50 day simple moving average is GBX 8.68 and its 200-day simple moving average is GBX 11.33. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42.

Scancell (LON:SCLP) last released its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) EPS for the quarter. On average, sell-side analysts predict that Scancell Holdings plc will post -2.5361112 EPS for the current year.

Scancell Company Profile

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.